Ruslan Fomenko, Certified Phlebotomist of the RIPL_Effect research team, delivered to the audience an interesting topic: attenuated T cells as a vaccine strategy in Systemic Lupus Erythematous (SLE). This topic was published by Huang et al. in 2016 in the Journal of Immunological Research (click here to access the article). In this self-controlled study, the authors extracted T cells from the patients, attenuated the extracted T cells by irradiation, and re-administered the attenudated T cells to the patients. The authors of the study reported that this vaccination strategy reduced anti-DNA antibodies and symptoms common among patients with SLE.